Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 212

    1.

    Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications.

    Kimura F, Hasegawa G, Obayashi H, Adachi T, Hara H, Ohta M, Fukui M, Kitagawa Y, Park H, Nakamura N, Nakano K, Yoshikawa T.

    Diabetes Care. 2003 Apr;26(4):1246-50.PMID: 12663605 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.

    Sözmen EY, Sözmen B, Delen Y, Onat T.

    Arch Med Res. 2001 Jul-Aug;32(4):283-7.PMID: 11440784 [PubMed - indexed for MEDLINE]Related articles

    4.

    Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population.

    Marklund SL, Nilsson P, Israelsson K, Schampi I, Peltonen M, Asplund K.

    J Intern Med. 1997 Jul;242(1):5-14.PMID: 9260561 [PubMed - indexed for MEDLINE]Related articles

    5.

    Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients.

    Adachi T, Inoue M, Hara H, Maehata E, Suzuki S.

    J Endocrinol. 2004 Jun;181(3):413-7.PMID: 15171689 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: a potential association with the risk of developing nephropathy.

    Zitouni K, Nourooz-Zadeh J, Harry D, Kerry SM, Betteridge DJ, Cappuccio FP, Earle KA.

    Diabetes Care. 2005 Jul;28(7):1698-703.PMID: 15983322 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evaluation of some biochemical changes in diabetic patients.

    Abou-Seif MA, Youssef AA.

    Clin Chim Acta. 2004 Aug 16;346(2):161-70.PMID: 15256317 [PubMed - indexed for MEDLINE]Related articles

    8.

    Serum markers of oxidative stress and severity of diabetic retinopathy.

    Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D.

    Diabetes Care. 2000 Feb;23(2):234-40.PMID: 10868837 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes.

    Tamai M, Furuta H, Kawashima H, Doi A, Hamanishi T, Shimomura H, Sakagashira S, Nishi M, Sasaki H, Sanke T, Nanjo K.

    Diabetes Res Clin Pract. 2006 Feb;71(2):140-5. Epub 2005 Jun 28.PMID: 15990193 [PubMed - indexed for MEDLINE]Related articles

    10.

    Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface.

    Adachi T, Yamada H, Yamada Y, Morihara N, Yamazaki N, Murakami T, Futenma A, Kato K, Hirano K.

    Biochem J. 1996 Jan 1;313 ( Pt 1):235-9.PMID: 8546689 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.

    Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH; EURODIAB IDDM Complications Study Group.

    Diabetes Care. 2001 Feb;24(2):316-22. Erratum in: Diabetes Care 2001 May;24(5):973. Georgino, F [corrected to Giorgino, F]. PMID: 11213885 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients.

    Lee SJ, Choi MG, Kim DS, Kim TW.

    Metabolism. 2006 Jan;55(1):1-7.PMID: 16324912 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impaired synthesis is not the reason for decreased activity of extracellular superoxide dismutase in patients with diabetes.

    Ciechanowski K, Kedzierska K, Gołembiewska E, Safranow K, Bober J, Domański L, Rózański J, Myślak M.

    Arch Med Res. 2005 Mar-Apr;36(2):148-53.PMID: 15847948 [PubMed - indexed for MEDLINE]Related articles

    14.

    Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.

    Nayak SB, Bhaktha G.

    Lipids Health Dis. 2005 Aug 10;4:15.PMID: 16092968 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

    Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control.

    Sözmen B, Delen Y, Girgin FK, Sözmen EY.

    Clin Biochem. 1999 Aug;32(6):423-7.PMID: 10667477 [PubMed - indexed for MEDLINE]Related articles

    17.

    Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.

    von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B, Korosoglou G, Morcos M, Campean V, Amann K, Lutz J, Heemann U, Nawroth PP, Bierhaus A, Humpert PM.

    Diabetes. 2009 Sep;58(9):2093-9. Epub 2009 Jun 9.PMID: 19509019 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus.

    Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, Savli H, Bayraktar N.

    Acta Diabetol. 2002 Sep;39(3):117-22.PMID: 12357295 [PubMed - indexed for MEDLINE]Related articles

    20.

    Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.

    Colak E, Majkić-Singh N, Stanković S, Srecković-Dimitrijević V, Djordjević PB, Lalić K, Lalić N.

    Ann Med. 2005;37(8):613-20.PMID: 16338763 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data